Literature DB >> 23575198

Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.

Karin Neukam1, Pablo Barreiro, Juan Macías, Ana Avellón, Celia Cifuentes, Luz Martín-Carbonero, José M Echevarría, Julio Vargas, Vicente Soriano, Juan A Pineda.   

Abstract

Chronic hepatitis E virus infection with rapid progression to cirrhosis is reported in 2 human immunodeficiency virus (HIV)-infected patients with severe immunosuppression. Monotherapy with ribavirin led to temporary viral response and marked improvement of liver damage. Chronic hepatitis E should be regarded as another opportunistic event within HIV infection.

Entities:  

Keywords:  HIV; chronic hepatitis E; cirrhosis; immunosuppression; ribavirin

Mesh：

Substances：

Year:  2013        PMID： 23575198     DOI： 10.1093/cid/cit224

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  30 in total

Review 1.  Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors:  Nassim Kamar; Sven Pischke
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

2.  Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India.

Authors:  Sachin Munjal; Neha Gupta; Raj K Sharma; Amit Gupta; Narain Prasad; Anupama Kaul; Dharmendra Bhadauria; Amit Goel; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2014-10-01

Review 3.  Clinical features and determinants of chronicity in hepatitis E virus infection.

Authors:  Shivakumar Narayanan; Ameer Abutaleb; Kenneth E Sherman; Shyam Kottilil
Journal:  J Viral Hepat       Date:  2019-02-05       Impact factor: 3.728

4.  Is Ribavirin Teratogenic in Humans? No Evidence So Far.

Authors:  Vicente Soriano; Pablo Barreiro
Journal:  Drug Saf       Date:  2017-12       Impact factor: 5.606

Review 5.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 6.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 7.  Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety.

Authors:  Soha Yazbek; Khalil Kreidieh; Sami Ramia
Journal:  Infection       Date:  2015-06-26       Impact factor: 3.553

Review 8.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

Review 9.  An update on hepatitis B, D, and E viruses.

Authors:  Jennifer Price
Journal:  Top Antivir Med       Date:  2014-01

Review 10.  Hepatitis E: What We Think We Know.

Authors:  Aradhna Seth; Kenneth E Sherman
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.